ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,605, issued on Aug. 12, was assigned to ANYGEN Co. LTD. (Gwangju, South Korea).
"Exenatide analog and use thereof" was invented by Jae Ha Ryu (Gwangju, South Korea), Sang Hyun Joo (Gwangju, South Korea) and Ye Ga Park (Gwangju, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to an exenatide analogue glycosylated to a specific residue, and a use thereof. The present invention provides a novel substance for treating diabetes, the novel substance exhibiting improved in vivo stability compared to conventional exenatides and analogues thereof. The present invention pertains to an exenatide dimer analogue and a us...